Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1991;11:561-568

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sambandam, T.
Right arrow Articles by Ekborg, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sambandam, T.
Right arrow Articles by Ekborg, S. L.

Arteriosclerosis and Thrombosis, Vol 11, 561-568, Copyright © 1991 by American Heart Association


ARTICLES

Specificity of the low density lipoprotein-glycosaminoglycan interaction

T Sambandam, JR Baker, JE Christner and SL Ekborg
Department of Biochemistry, University of Alabama, Birmingham 35294.

There is ample documentation of the binding of chondroitin sulfate/dermatan sulfate proteoglycans to low density lipoprotein (LDL) both in vivo and in vitro. The interaction of these two species may be an early and important step in atherogenesis. Therefore, there is interest in defining the features of both molecules that are critical for their interaction. We employed a recently described competitive microassay that measures initial binding of proteoglycan to immobilized LDL. We confirmed the work of others that it is the apolipoprotein B component and, at least in part, a heparin-binding domain of LDL that are responsible for binding chondroitin sulfate/dermatan sulfate proteoglycans. The principal thrust of our study was concerned with the effects of a glycosaminoglycan's degree of sulfation on the binding to LDL. Initial experiments comparing dermatan sulfate and chondroitin sulfate proteoglycans indicated that the former was more efficient at binding LDL than the latter and that oversulfation, rather than chain length or iduronate content, was the preeminent feature involved. Additional binding studies with dermatan sulfate, chemically sulfated chondroitin-4-sulfate, and naturally occurring oversulfated chondroitin sulfates indicated that the degree of sulfation, not the position of sulfation, determined affinity for LDL. These results suggest that studies should be undertaken to determine whether oversulfated segments of glycosaminoglycans are especially involved in associations with LDL, leading to lipid accumulation, in the artery wall.


This article has been cited by other articles:


Home page
Circ. Res.Home page
T. N. Wight and M. J. Merrilees
Proteoglycans in Atherosclerosis and Restenosis: Key Roles for Versican
Circ. Res., May 14, 2004; 94(9): 1158 - 1167.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
C. D. Meyers, L. R. Tannock, T. N. Wight, and A. Chait
Statin-exposed vascular smooth muscle cells secrete proteoglycans with decreased binding affinity for LDL
J. Lipid Res., November 1, 2003; 44(11): 2152 - 2160.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
L. R. Tannock, P. J. Little, T. N. Wight, and A. Chait
Arterial smooth muscle cell proteoglycans synthesized in the presence of glucosamine demonstrate reduced binding to LDL
J. Lipid Res., January 1, 2002; 43(1): 149 - 157.
[Abstract] [Full Text] [PDF]


Home page
Microbiol. Mol. Biol. Rev.Home page
M. J. Jedrzejas
Pneumococcal Virulence Factors: Structure and Function
Microbiol. Mol. Biol. Rev., June 1, 2001; 65(2): 187 - 207.
[Abstract] [Full Text] [PDF]


Home page
CROBMHome page
G. Embery, R. Hall, R. Waddington, D. Septier, and M. Goldberg
Proteoglycans in Dentinogenesis
Critical Reviews in Oral Biology & Medicine, January 1, 2001; 12(4): 331 - 349.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. D. O'Brien, K. L. Olin, C. E. Alpers, W. Chiu, M. Ferguson, K. Hudkins, T. N. Wight, and A. Chait
Comparison of Apolipoprotein and Proteoglycan Deposits in Human Coronary Atherosclerotic Plaques : Colocalization of Biglycan With Apolipoproteins
Circulation, August 11, 1998; 98(6): 519 - 527.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Lyon, J. A. Deakin, H. Rahmoune, D. G. Fernig, T. Nakamura, and J. T. Gallagher
Hepatocyte Growth Factor/Scatter Factor Binds with High Affinity to Dermatan Sulfate
J. Biol. Chem., January 2, 1998; 273(1): 271 - 278.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. O. Pentikainen, K. Oorni, R. Lassila, and P. T. Kovanen
The Proteoglycan Decorin Links Low Density Lipoproteins with Collagen Type I
J. Biol. Chem., March 21, 1997; 272(12): 7633 - 7638.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Swarnakar, J. Beers, D. K. Strickland, S. Azhar, and D. L. Williams
The Apolipoprotein E-dependent Low Density Lipoprotein Cholesteryl Ester Selective Uptake Pathway in Murine Adrenocortical Cells Involves Chondroitin Sulfate Proteoglycans and an alpha 2-Macroglobulin Receptor
J. Biol. Chem., June 8, 2001; 276(24): 21121 - 21128.
[Abstract] [Full Text] [PDF]